| Ashley Schiraldi, MSW, LCSW | |
|
1088 Highway 34, Aberdeen, NJ 07747-1948 | |
| (732) 290-1700 | |
| Not Available |
| Full Name | Ashley Schiraldi |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | 1088 Highway 34, Aberdeen, New Jersey |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1831661396 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 44SC05818500 (New Jersey) | Primary |
| Entity Name | Ocean Health Initiatives, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043306574 PECOS PAC ID: 2062405277 Enrollment ID: O20040405001022 |
News Archive
A study comparing the bone health of 105 post-menopausal vegan Buddhist nuns and 105 non-vegetarian women, matched in every other physical respect, has produced a surprising result.
Research suggests that there is no long-term advantage, in terms of cardioprotection or event-free survival, from giving continuous instead of bolus doxorubicin infusion in children with acute lymphoblastic leukemia.
Spinal Restoration, Inc. announced today it has received a Special Protocol Assessment concurrence letter from the U.S. Food and Drug Administration (FDA) for the design of its Phase 3 study of the Biostat System for the treatment of chronic discogenic low back pain.
Sangamo BioSciences, Inc. announced today that the company completed enrollment of its Phase 2b double-blind, placebo-controlled clinical trial (SB-509-901) in subjects with diabetic neuropathy (DN). The company expects to have efficacy data from this study in the second half of 2011. The company also plans to present the first human clinical data from its Phase 1 trials of SB-728-T in HIV/AIDS in the first quarter of 2011.
› Verified 6 days ago
| Entity Name | Cpc Behavioral Healthcare Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366497356 PECOS PAC ID: 3971593161 Enrollment ID: O20040518000822 |
News Archive
A study comparing the bone health of 105 post-menopausal vegan Buddhist nuns and 105 non-vegetarian women, matched in every other physical respect, has produced a surprising result.
Research suggests that there is no long-term advantage, in terms of cardioprotection or event-free survival, from giving continuous instead of bolus doxorubicin infusion in children with acute lymphoblastic leukemia.
Spinal Restoration, Inc. announced today it has received a Special Protocol Assessment concurrence letter from the U.S. Food and Drug Administration (FDA) for the design of its Phase 3 study of the Biostat System for the treatment of chronic discogenic low back pain.
Sangamo BioSciences, Inc. announced today that the company completed enrollment of its Phase 2b double-blind, placebo-controlled clinical trial (SB-509-901) in subjects with diabetic neuropathy (DN). The company expects to have efficacy data from this study in the second half of 2011. The company also plans to present the first human clinical data from its Phase 1 trials of SB-728-T in HIV/AIDS in the first quarter of 2011.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ashley Schiraldi, MSW, LCSW 45 Drew Ct, Manalapan, NJ 07726-5116 Ph: (908) 907-3376 | Ashley Schiraldi, MSW, LCSW 1088 Highway 34, Aberdeen, NJ 07747-1948 Ph: (732) 290-1700 |
News Archive
A study comparing the bone health of 105 post-menopausal vegan Buddhist nuns and 105 non-vegetarian women, matched in every other physical respect, has produced a surprising result.
Research suggests that there is no long-term advantage, in terms of cardioprotection or event-free survival, from giving continuous instead of bolus doxorubicin infusion in children with acute lymphoblastic leukemia.
Spinal Restoration, Inc. announced today it has received a Special Protocol Assessment concurrence letter from the U.S. Food and Drug Administration (FDA) for the design of its Phase 3 study of the Biostat System for the treatment of chronic discogenic low back pain.
Sangamo BioSciences, Inc. announced today that the company completed enrollment of its Phase 2b double-blind, placebo-controlled clinical trial (SB-509-901) in subjects with diabetic neuropathy (DN). The company expects to have efficacy data from this study in the second half of 2011. The company also plans to present the first human clinical data from its Phase 1 trials of SB-728-T in HIV/AIDS in the first quarter of 2011.
› Verified 6 days ago
Ms. Charise Atiba, LCSW, LCADC Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 1088 Highway 34, Aberdeen, NJ 07747 Phone: 732-290-1700 | |
Elizabeth Brodie, Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 91 Avondale Ln, Aberdeen, NJ 07747 Phone: 732-372-8589 | |
Kathryn Ashley, LICSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 435 Line Rd, Aberdeen, NJ 07747 Phone: 617-470-1321 | |
Magan Lee, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1323 Highway 34, Suite D, Aberdeen, NJ 07747 Phone: 732-598-6202 | |
Victoria Nicole Larsen, LCSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 1088 State Route 34, Aberdeen, NJ 07747 Phone: 732-290-1700 |